---
title: "anakinra - Rheumatoid arthritis"
sidebar: mydoc_sidebar
permalink: anakinrarheumatoidarthritis.html
toc: false 
---

{% include image.html url="images/anakinrarheumatoidarthritis.png" file="anakinrarheumatoidarthritis.png" alt="anakinrarheumatoidarthritis" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D053590 | Anakinra | Drug |
| UniProt:P14778 | Interleukin-1 receptor type 1 | Protein |
| GO:0004908 | Interleukin-1 receptor activity | MolecularActivity |
| REACT:R-HSA-1592389 | Activation of Matrix Metalloproteinases | Pathway |
| HP:0100773 | Cartilage destruction | PhenotypicFeature |
| MESH:D001172 | Rheumatoid arthritis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Anakinra | DECREASES ACTIVITY OF | Interleukin-1 Receptor Type 1 |
| Interleukin-1 Receptor Type 1 | PARTICIPATES IN | Interleukin-1 Receptor Activity |
| Interleukin-1 Receptor Activity | POSITIVELY REGULATES | Activation Of Matrix Metalloproteinases |
| Activation Of Matrix Metalloproteinases | POSITIVELY REGULATES | Cartilage Destruction |
| Cartilage Destruction | OCCURS IN | Rheumatoid Arthritis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00026#mechanism-of-action](https://go.drugbank.com/drugs/DB00026#mechanism-of-action){:target="_blank"}